Company Overview
Snapshot
Founded in March 2017 by Rony Oren Benaroya and Amir Ayali, IBI-Ag operates with 11–50 employees. The company has secured $11.64M across 7 funding rounds from 9 investors. In November 2025, IBI-Ag completed a Series A round led by Corteva.
Business overview
IBI-Ag is a crop protection company focused on developing biological solutions for insect control. The company utilizes breakthrough technology to produce efficient, selective, and safe bio-insecticides, aiming to redefine sustainable agriculture by offering environmentally friendly alternatives to traditional pesticides. Its technology is designed for cost-effectiveness through fermentation suitability, enabling farmers to produce agricultural produce at a lower cost. IBI-Ag operates within the Agriculture & Food Technologies sector, specifically targeting the Ag Tech and Sustainable Farming markets globally.
Strategic signal
In November 2025, IBI-Ag completed a Series A funding round led by Corteva. This investment signals strong market validation for IBI-Ag's bio-insecticide technology and its potential to scale, reinforcing investor confidence in sustainable agricultural solutions and the company's immediate forward trajectory in the crop protection industry.
Log in to access full profile ›Company Intelligence Q&A
- Who are the founders of IBI-Ag?
- IBI-Ag was co-founded by Rony Oren Benaroya, who serves as CTO, and Amir Ayali, who is a Scientific Advisor.
- What is IBI-Ag's core technology?
- IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe biological insect-control solutions that are cost-effective due to their fermentation suitability.
- Which investors participated in IBI-Ag's June 2021 funding round?
- In June 2021, IBI-Ag completed a funding round with participation from Bayer Trendlines Ag Innovation Fund.